Der Report

Tiefgehende Einblicke in Unternehmensfinanzierung, Wachstumsstrategien und Markterkenntnisse der innovativsten Unternehmen der Welt

196 Berichte und es werden mehr

Täglich aktualisiert mit den neuesten Marktinformationen
HealthTech
Galvenize Therapeutics

Galvenize Therapeutics raises $100M Series C

Galvenize Therapeutics raises $100M in Series C. Developer of pulsed electric field therapies for cardiac ablation procedures...

Editorial Team
Sep 16, 2025
0 min read$100M
MedTech
Galvenize Therapeutics

Galvenize Therapeutics Raises $100M Series C to Transform MedTech

Galvenize Therapeutics has secured $100M Series C in funding to accelerate growth and innovation in the medtech sector. Medical device company developing pulsed electric field therapies for cardiac ablation and tumor treatment...

David Chen
Oct 22, 2025
0 min read$100M Series C
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min read$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min read$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read$153M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min read$113M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
0 min read$205M
Biotech
Kailera Therapeutics

Kailera Therapeutics raises $400M Series A at $1.5B valuation

Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...

Editorial Team
Oct 1, 2024
0 min read$400M
Biotech
Expedition Therapeutics

Expedition Therapeutics raises $165M Series B at $850M valuation

Expedition Therapeutics raises $165M in Series B at $850M valuation. Developing novel therapeutics for cardiometabolic diseases...

Editorial Team
Jan 15, 2025
0 min read$165M
Seite 1

9 Berichte angezeigt • Seite 1 • Kategorie: all

Bleiben Sie dem Markt voraus

Erhalten Sie wöchentliche Insights direkt in Ihren Posteingang. Kein Spam, nur Intelligence.